• GlucoTrack filed an amended Form 8-K to correct its disclosure of an Exchange Agreement, replacing a July 22 version with a July 24 agreement.
• The revised deal partitions a USD 900,000 promissory note from an existing note, leaving the remaining balance outstanding under prior terms.
• The investor can exchange the partitioned note into common stock at a “Minimum Price” tied to recent Nasdaq closing prices, with share delivery due by Aug. 31, 2026.
• Issuance is capped by a 9.99% beneficial ownership limit, which could require multiple tranches and leave some of the note outstanding.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035242), on July 29, 2026, and is solely responsible for the information contained therein.